Clinical evidence for immunomodulation induced by high-dose melphalan and autologous blood stem cell transplantation as cause for complete clinical remission of multiple myeloma-associated cryoglobulin-vasculitis

Clinical Remission ◽

Clinical Evidence ◽

Autologous Blood ◽

High Dose ◽

Complete Clinical Remission ◽

High Dose Melphalan ◽

Lenalidomide and dexamethasone with or without high-dose melphalan and autologous blood stem cell transplantation followed by lenalidomide maintenance in the treatment of relapsed multiple myeloma

http://isrctn.org/> ◽

10.1186/isrctn16345835 ◽

2013 ◽

Author(s):

Hartmut Goldschmidt

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Cell Transplantation ◽

Autologous Blood ◽

Blood Stem Cell ◽

High Dose ◽

High Dose Melphalan ◽

Singleversustandem high-dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long-term results from the phase III GMMG-HD2 trial

British Journal of Haematology ◽

10.1111/bjh.13994 ◽

2016 ◽

Vol 173 (5) ◽

pp. 731-741 ◽

Cited By ~ 28

Author(s):

Elias K. Mai ◽

Axel Benner ◽

Uta Bertsch ◽

Peter Brossart ◽

Annette Hänel ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Autologous Blood ◽

Phase Iii ◽

Long Term Results ◽

High Dose ◽

High Dose Melphalan ◽

A Phase I/II Study of Escalating Doses of Bortezomib in Conjunction with High-Dose Melphalan as a Conditioning Regimen for Salvage Autologous Peripheral Blood Stem Cell Transplantation in Patients with Multiple Myeloma

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2016.08.017 ◽

2016 ◽

Vol 22 (12) ◽

pp. 2165-2171 ◽

Cited By ~ 9

Author(s):

Noa Biran ◽

Scott D. Rowley ◽

David H. Vesole ◽

Shijia Zhang ◽

Michele L. Donato ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Phase I ◽

Peripheral Blood ◽

Peripheral Blood Stem Cell ◽

Conditioning Regimen ◽

High Dose ◽

High Dose Melphalan ◽

Marked Recovery of Severe Renal Lesions in POEMS Syndrome With High-Dose Melphalan Therapy Supported by Autologous Blood Stem Cell Transplantation

American Journal of Kidney Diseases ◽

10.1053/j.ajkd.2006.01.004 ◽

2006 ◽

Vol 47 (4) ◽

pp. 672-679 ◽

Cited By ~ 30

Author(s):

Satoru Sanada ◽

Susumu Ookawara ◽

Hiroki Karube ◽

Tetsuro Shindo ◽

Toshikazu Goto ◽

...

Keyword(s):

Stem Cell ◽

Cell Transplantation ◽

Autologous Blood ◽

Poems Syndrome ◽

Blood Stem Cell ◽

High Dose ◽

Renal Lesions ◽

High Dose Melphalan ◽

High dose chemoradiotherapy and autologous blood stem cell transplantation for patients with multiple myeloma

The International Journal Of Cell Cloning ◽

10.1002/stem.5530100745 ◽

1992 ◽

Vol 10 (S1) ◽

pp. 141-141 ◽

Cited By ~ 1

Author(s):

J. P. Fermand ◽

S. Chevret ◽

C. Hennequin ◽

M. Gerota ◽

M. Benbunan ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Cell Transplantation ◽

Autologous Blood ◽

Blood Stem Cell ◽

High Dose ◽

Veno-Occlusive Disease of the Liver after High-Dose Cytoreductive Therapy with Busulfan and Melphalan for Autologous Blood Stem Cell Transplantation in Multiple Myeloma Patients

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2007.08.002 ◽

2007 ◽

Vol 13 (12) ◽

pp. 1448-1454 ◽

Cited By ~ 68

Author(s):

Enric Carreras ◽

Laura Rosiñol ◽

Maria José Terol ◽

Adrián Alegre ◽

Felipe de Arriba ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Cell Transplantation ◽

Autologous Blood ◽

Occlusive Disease ◽

Blood Stem Cell ◽

High Dose ◽

471: An Aprepitant Containing Regimen Controls the Delayed Nausea and Vomiting Associated with High-dose Melphalan Followed by Autologous Peripheral Blood Stem Cell Transplantation in Patients with Multiple Myeloma

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2007.12.481 ◽

2008 ◽

Vol 14 (2) ◽

pp. 166

Author(s):

T.P. Bechtel ◽

B.S. Crawford ◽

S.M. Gordon ◽

S. Penza ◽

C. Hofmeister ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Cell Transplantation ◽

Peripheral Blood ◽

Peripheral Blood Stem Cell ◽

High Dose ◽

Delayed Nausea ◽

High Dose Melphalan ◽

Pegfilgrastim compared with filgrastim after high-dose melphalan and autologous hematopoietic peripheral blood stem cell transplantation in multiple myeloma patients

European Journal Of Haematology ◽

10.1111/j.1600-0609.2006.00736.x ◽

2006 ◽

Vol 77 (5) ◽

pp. 410-415 ◽

Cited By ~ 30

Author(s):

Massimo Martino ◽

Giulia Praticò ◽

Giuseppe Messina ◽

Giuseppe Irrera ◽

Elisabetta Massara ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Cell Transplantation ◽

Peripheral Blood ◽

Peripheral Blood Stem Cell ◽

Blood Stem Cell ◽

High Dose ◽

High Dose Melphalan ◽

Predictive factors for successful salvage high-dose therapy in patients with multiple myeloma relapsing after autologous blood stem cell transplantation

Leukemia & Lymphoma ◽

10.3109/10428194.2011.575967 ◽

2011 ◽

Vol 52 (8) ◽

pp. 1455-1462 ◽

Cited By ~ 42

Author(s):

Roland Fenk ◽

Vanessa Liese ◽

Florian Neubauer ◽

Ingmar Bruns ◽

Mustafa Kondakci ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Cell Transplantation ◽

Predictive Factors ◽

Autologous Blood ◽

High Dose ◽

High Dose Therapy ◽

Dose Therapy ◽

Secondary primary malignancies in patients with multiple myeloma treated with high-dose chemotherapy and autologous blood stem cell transplantation

British Journal of Haematology ◽

10.1111/j.1365-2141.2011.08905.x ◽

2011 ◽

Vol 156 (5) ◽

pp. 683-686 ◽

Cited By ~ 13

Author(s):

Roland Fenk ◽

Florian Neubauer ◽

Ingmar Bruns ◽

Thomas Schröder ◽

Ulrich Germing ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Cell Transplantation ◽

Autologous Blood ◽

High Dose Chemotherapy ◽

Blood Stem Cell ◽

High Dose ◽